Biotech · Private company · Stony Brook, NY, US
Blood Cell Technologies, LLC
Track this companyFree. Adds Blood Cell Technologies, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of Second Generation BLVRB Inhibitors for Treating Chemotherapy Induced ThrombocytopeniaFiscal year 2026 · $875.1KNIH RePORTER 4R44CA302180-02 · fetched Nov 12, 2026
- Development of Second Generation BLVRB Inhibitors for Treating Chemotherapy Induced ThrombocytopeniaFiscal year 2025 · $400KNIH RePORTER 1R44CA302180-01A1 · fetched Nov 12, 2026